Literature DB >> 15837152

Melanin pigmentary disorders: treatment update.

Jean-Paul Ortonne1, Thierry Passeron.   

Abstract

Most of the melanin pigmentary disorders are cosmetically important and have a strong impact on the quality of life of affected individuals. This article examines recent advances in the treatment of melanin pigmentary disorder including hypermelanosis and hypomelanosis. The development of laser technologies has completed the use of the increasing number of bleaching agents in treating hyperpigmented lesions. The treatment of hypomelanotic disorders is still often disappointing, but new therapeutic options provide encouraging results.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15837152     DOI： 10.1016/j.det.2005.01.001

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN： 0733-8635            Impact factor:   3.478


  17 in total

1.  Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color.

Authors:  Erica C Davis; Valerie D Callender
Journal:  J Clin Aesthet Dermatol       Date:  2010-07

2.  What should be considered in treatment of melasma.

Authors:  Hee Young Kang; Jean-Paul Ortonne
Journal:  Ann Dermatol       Date:  2010-11-05       Impact factor: 1.444

3.  A review of acne in ethnic skin: pathogenesis, clinical manifestations, and management strategies.

Authors:  Erica C Davis; Valerie D Callender
Journal:  J Clin Aesthet Dermatol       Date:  2010-04

4.  Downregulation of melanocyte-specific facultative melanogenesis by 4-hydroxy-3-methoxycinnamaldehyde acting as a cAMP antagonist.

Authors:  Eunmiri Roh; In-Yeong Jeong; Hyoeun Shin; Sukgil Song; Nam Doo Kim; Sang-Hun Jung; Jin Tae Hong; Seung Ho Lee; Sang-Bae Han; Youngsoo Kim
Journal:  J Invest Dermatol       Date:  2013-08-07       Impact factor: 8.551

5.  Dual Effect of Photobiomodulation on Melasma: Downregulation of Hyperpigmentation and Enhanced Solar Resistance-A Pilot Study.

Authors:  Daniel Barolet
Journal:  J Clin Aesthet Dermatol       Date:  2018-04-01

6.  Inhibition of melanogenesis by the antidiabetic metformin.

Authors:  Abdelali Lehraiki; Patricia Abbe; Michael Cerezo; Florian Rouaud; Claire Regazzetti; Bérengère Chignon-Sicard; Thierry Passeron; Corine Bertolotto; Robert Ballotti; Stéphane Rocchi
Journal:  J Invest Dermatol       Date:  2014-04-22       Impact factor: 8.551

7.  cAMP-dependent activation of protein kinase A as a therapeutic target of skin hyperpigmentation by diphenylmethylene hydrazinecarbothioamide.

Authors:  Hyoeun Shin; Seung Deok Hong; Eunmiri Roh; Sang-Hun Jung; Won-Jea Cho; Sun Hong Park; Da Young Yoon; Seon Mi Ko; Bang Yeon Hwang; Jin Tae Hong; Tae-Young Heo; Sang-Bae Han; Youngsoo Kim
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

8.  Modifying skin pigmentation - approaches through intrinsic biochemistry and exogenous agents.

Authors:  Michaela Brenner; Vincent J Hearing
Journal:  Drug Discov Today Dis Mech       Date:  2008

9.  A study comparing chemical peeling using modified Jessner's solution and 15% trichloroacetic Acid versus 15% trichloroacetic acid in the treatment of melasma.

Authors:  Omar Soliman Safoury; Nagla Mohamed Zaki; Eman Ahmad El Nabarawy; Eman Abas Farag
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

10.  Comparative study of 15% TCA peel versus 35% glycolic acid peel for the treatment of melasma.

Authors:  Neerja Puri
Journal:  Indian Dermatol Online J       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.